Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis

Smith Giri, Michelle Chi, Benny Johnson, David McCormick, Omer Jamy, Vijaya Raj Bhatt, Michael Martin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Compared to secondary acute myeloid leukemia, secondary acute lymphoblastic leukemia (sALL) is poorly characterized. We utilized data from the Surveillance, Epidemiology, and End Results (SEER) 13 database to further elucidate patient characteristics and prognostic factors in sALL. Cases of adult de novo acute lymphoblastic leukemia (ALL) and sALL in patients with primary breast, rectum, cervix, or ovarian cancers or lymphoma with a latency period of at least 12 months were identified within the SEER 13 database. Survival in sALL and de novo ALL were compared after propensity matching based on age, gender, race, ALL subtype, and year of diagnosis. 4124 cases of de novo ALL and 79 cases of sALL were identified. sALL patients were older at diagnosis (median 62 years vs 44 years; p < 0.01). Overall survival (OS) in sALL was lower than de novo ALL (median 8 months vs 11 months), 1 year OS: 35% vs 47% (p = 0.05), 2 year OS: 16% vs 31% (p < 0.01), and 5 year OS: 7% vs 21% (p < 0.01). Multivariate analysis revealed sALL as an independent predictor of worsened survival (adjusted HR 1.54; 95% CI 1.16-2.04, p < 0.01) after propensity matching.

Original languageEnglish (US)
Pages (from-to)1342-1346
Number of pages5
JournalLeukemia Research
Volume39
Issue number12
DOIs
StatePublished - Jul 1 2015
Externally publishedYes

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Survival
Epidemiology
Databases
Rectal Neoplasms
Acute Myeloid Leukemia
Uterine Cervical Neoplasms
Ovarian Neoplasms
Lymphoma
Breast
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. / Giri, Smith; Chi, Michelle; Johnson, Benny; McCormick, David; Jamy, Omer; Bhatt, Vijaya Raj; Martin, Michael.

In: Leukemia Research, Vol. 39, No. 12, 01.07.2015, p. 1342-1346.

Research output: Contribution to journalArticle

Giri, S, Chi, M, Johnson, B, McCormick, D, Jamy, O, Bhatt, VR & Martin, M 2015, 'Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis', Leukemia Research, vol. 39, no. 12, pp. 1342-1346. https://doi.org/10.1016/j.leukres.2015.09.011
Giri, Smith ; Chi, Michelle ; Johnson, Benny ; McCormick, David ; Jamy, Omer ; Bhatt, Vijaya Raj ; Martin, Michael. / Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. In: Leukemia Research. 2015 ; Vol. 39, No. 12. pp. 1342-1346.
@article{ef17584ab1dd48399941b5d09f16dcea,
title = "Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis",
abstract = "Compared to secondary acute myeloid leukemia, secondary acute lymphoblastic leukemia (sALL) is poorly characterized. We utilized data from the Surveillance, Epidemiology, and End Results (SEER) 13 database to further elucidate patient characteristics and prognostic factors in sALL. Cases of adult de novo acute lymphoblastic leukemia (ALL) and sALL in patients with primary breast, rectum, cervix, or ovarian cancers or lymphoma with a latency period of at least 12 months were identified within the SEER 13 database. Survival in sALL and de novo ALL were compared after propensity matching based on age, gender, race, ALL subtype, and year of diagnosis. 4124 cases of de novo ALL and 79 cases of sALL were identified. sALL patients were older at diagnosis (median 62 years vs 44 years; p < 0.01). Overall survival (OS) in sALL was lower than de novo ALL (median 8 months vs 11 months), 1 year OS: 35{\%} vs 47{\%} (p = 0.05), 2 year OS: 16{\%} vs 31{\%} (p < 0.01), and 5 year OS: 7{\%} vs 21{\%} (p < 0.01). Multivariate analysis revealed sALL as an independent predictor of worsened survival (adjusted HR 1.54; 95{\%} CI 1.16-2.04, p < 0.01) after propensity matching.",
author = "Smith Giri and Michelle Chi and Benny Johnson and David McCormick and Omer Jamy and Bhatt, {Vijaya Raj} and Michael Martin",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.leukres.2015.09.011",
language = "English (US)",
volume = "39",
pages = "1342--1346",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis

AU - Giri, Smith

AU - Chi, Michelle

AU - Johnson, Benny

AU - McCormick, David

AU - Jamy, Omer

AU - Bhatt, Vijaya Raj

AU - Martin, Michael

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Compared to secondary acute myeloid leukemia, secondary acute lymphoblastic leukemia (sALL) is poorly characterized. We utilized data from the Surveillance, Epidemiology, and End Results (SEER) 13 database to further elucidate patient characteristics and prognostic factors in sALL. Cases of adult de novo acute lymphoblastic leukemia (ALL) and sALL in patients with primary breast, rectum, cervix, or ovarian cancers or lymphoma with a latency period of at least 12 months were identified within the SEER 13 database. Survival in sALL and de novo ALL were compared after propensity matching based on age, gender, race, ALL subtype, and year of diagnosis. 4124 cases of de novo ALL and 79 cases of sALL were identified. sALL patients were older at diagnosis (median 62 years vs 44 years; p < 0.01). Overall survival (OS) in sALL was lower than de novo ALL (median 8 months vs 11 months), 1 year OS: 35% vs 47% (p = 0.05), 2 year OS: 16% vs 31% (p < 0.01), and 5 year OS: 7% vs 21% (p < 0.01). Multivariate analysis revealed sALL as an independent predictor of worsened survival (adjusted HR 1.54; 95% CI 1.16-2.04, p < 0.01) after propensity matching.

AB - Compared to secondary acute myeloid leukemia, secondary acute lymphoblastic leukemia (sALL) is poorly characterized. We utilized data from the Surveillance, Epidemiology, and End Results (SEER) 13 database to further elucidate patient characteristics and prognostic factors in sALL. Cases of adult de novo acute lymphoblastic leukemia (ALL) and sALL in patients with primary breast, rectum, cervix, or ovarian cancers or lymphoma with a latency period of at least 12 months were identified within the SEER 13 database. Survival in sALL and de novo ALL were compared after propensity matching based on age, gender, race, ALL subtype, and year of diagnosis. 4124 cases of de novo ALL and 79 cases of sALL were identified. sALL patients were older at diagnosis (median 62 years vs 44 years; p < 0.01). Overall survival (OS) in sALL was lower than de novo ALL (median 8 months vs 11 months), 1 year OS: 35% vs 47% (p = 0.05), 2 year OS: 16% vs 31% (p < 0.01), and 5 year OS: 7% vs 21% (p < 0.01). Multivariate analysis revealed sALL as an independent predictor of worsened survival (adjusted HR 1.54; 95% CI 1.16-2.04, p < 0.01) after propensity matching.

UR - http://www.scopus.com/inward/record.url?scp=84945589089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945589089&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2015.09.011

DO - 10.1016/j.leukres.2015.09.011

M3 - Article

VL - 39

SP - 1342

EP - 1346

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 12

ER -